Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

STADION FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   4.2% 3.2% 3.3% 4.0% 3.0% 4.0% 14.3% 14.3%   Credit score (0-100)   50 57 55 48 57 49 15 15   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   79.5 31.5 115 67.0 104 114 0.0 0.0   EBITDA   79.5 31.5 115 67.0 104 114 0.0 0.0   EBIT   59.7 11.8 78.9 28.0 75.9 94.5 0.0 0.0   Pre-tax profit (PTP)   54.5 2.4 69.9 21.0 72.5 87.5 0.0 0.0   Net earnings   42.5 1.9 54.5 16.4 56.5 68.2 0.0 0.0   Pre-tax profit without non-rec. items   54.5 2.4 69.9 21.0 72.5 87.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   68.4 48.7 109 70.2 41.8 22.5 0.0 0.0   Shareholders equity total   381 383 437 454 510 579 0.0 0.0   Interest-bearing liabilities   0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   507 505 614 564 714 733 0.0 0.0   Net Debt   -209 -257 -281 -300 -381 -563 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   79.5 31.5 115 67.0 104 114 0.0 0.0   Gross profit growth   38.8% -60.3% 263.7% -41.6% 55.7% 9.1% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   507 505 614 564 714 733 0 0   Balance sheet change%   4.2% -0.3% 21.5% -8.1% 26.6% 2.6% -100.0% 0.0%   Added value   79.5 31.5 114.7 67.0 114.9 113.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -39 -39 25 -78 -57 -39 -22 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   75.2% 37.4% 68.8% 41.8% 72.7% 83.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.0% 2.3% 14.1% 4.8% 11.9% 13.6% 0.0% 0.0%   ROI %   16.5% 3.0% 18.8% 6.3% 15.7% 18.1% 0.0% 0.0%   ROE %   11.8% 0.5% 13.3% 3.7% 11.7% 12.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   75.2% 75.5% 71.1% 80.5% 71.4% 79.0% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -263.1% -814.3% -244.8% -447.1% -365.5% -494.6% 0.0% 0.0%   Gearing %   0.0% 4.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 104.8% 99.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   3.2 3.4 2.6 4.0 3.0 4.4 0.0 0.0   Current Ratio   3.6 3.8 2.9 4.5 3.3 4.6 0.0 0.0   Cash and cash equivalent   209.1 274.8 280.8 299.5 381.3 563.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   315.5 335.8 329.5 383.6 468.6 556.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0